Predicate |
Object |
assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_64a7e356a40aeaa7bb05fc8eb4fbdb3a http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_5b755982699e3ea5199d569ee5f5344c |
classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D471-04 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D519-00 |
classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D519-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D471-04 |
filingDate |
2018-10-10-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
grantDate |
2020-08-18-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_26eb52475933f1784d96cfacb2798174 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_f4b6783f302f237147a105c65bc8079e http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_4696fe2804e678644400258894834145 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_6da69117dbbefded16f6fa3f6748dda4 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_6d5d34fc4951c63c5b87317dbc0825ee http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_8171265893a69f6ba16df78d585679cb http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_b52b36ac8838cf6841765d61744d5ab1 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_1dbc8357bddb8baa968301d1cef9de08 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_68461077a8f19a0de99eaaffa313035c http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_122c6d3cfe896a6f5b11562c9e82bcf8 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_e4364f0fe06a6b166ebfe9090fc47eba http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_18f7ee758ba54097ed3a2f19bb99f925 |
publicationDate |
2020-08-18-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationNumber |
US-10745419-B2 |
titleOfInvention |
Process for the preparation of 6-(2-hydroxy-2-methylpropoxy)-4-(6-(6-((6-methoxypyridin-3-yl)methyl)-3,6-diazabicyclo[3.1.1]heptan-3-yl)pyridin-3-yl)pyrazolo[1,5-a]pyridine-3-carbonitrile |
abstract |
In some embodiments, provided herein is a process for preparing a compound of Formula I n nor a pharmaceutically acceptable salt thereof, as disclosed herein. |
isCitedBy |
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-11098064-B2 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2021211380-A1 |
priorityDate |
2017-10-10-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
type |
http://data.epo.org/linked-data/def/patent/Publication |